Tepotinib in patients with advanced non-small cell lung cancer (NSCLC) harboring MET exon 14-skipping mutations: Phase II trial Meeting Abstract


Authors: Felip, E.; Horn, L.; Patel, J. D.; Sakai, H.; Scheele, J.; Bruns, R.; Paik, P. K.
Abstract Title: Tepotinib in patients with advanced non-small cell lung cancer (NSCLC) harboring MET exon 14-skipping mutations: Phase II trial
Meeting Title: 54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 15 Suppl.
Meeting Dates: 2018 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-20
Start Page: 464s
Language: English
ACCESSION: WOS:000442916003190
DOI: 10.1200/JCO.2018.36.15_suppl.9016
PROVIDER: wos
Notes: Meeting Abstract: 9016 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul K Paik
    255 Paik